Why the study?
Does early peritoneal dialysis improve outcomes in a neonate with lisinopril-induced multiorgan failure?
Does early peritoneal dialysis improve outcomes in a neonate with lisinopril-induced multiorgan failure?
Early peritoneal dialysis may facilitate recovery in neonates with lisinopril-induced multiorgan failure, though hemodialysis or hemofiltration might offer better drug clearance.
May support peritoneal dialysis for recovery in neonatal lisinopril toxicity despite poor clearance; leaves open optimal modality.
In general, angiotensin converting enzyme (ACE) inhibitors should be discontinued in pregnancy, as they can induce an ACE fetopathy. For the treatment of the latter, early peritoneal dialysis is recommended for in utero exposure to captopril and enalapril, although the outcome is poor. Early peritoneal dialysis has not previously been reported for lisinopril induced multiorgan failure. A case is reported in which treatment was given on postnatal day 3. The patient recovered from oligoanuria to almost normal renal function, and heart, brain, and musculoskeletal injury was reversible. This is despite relatively poor clearance of the drug through peritoneal dialysis. Analysis of the pharmacokinetic data suggests that haemodialysis or haemofiltration would be more efficacious for removal of the drug, and these treatments should be performed if available.
No takes yet. Share an insight, caveat, or question.
Guido Filler (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: